Trader Note — 9789 total
Wetour Robotics Limited heads into the weekend having gained 17% on the week, yet the number of shares sold short multiplied more than sixfold in the same period — a divergence that makes the stock one of the more…
Seadrill enters the back half of May with a head of steam. The stock climbed 9% this week to $52.70, its strongest weekly gain since the start of the year, and the catalyst is clear: a high-conviction analyst upgrade…
SHPH heads into its May 21 earnings call as a company mid-transformation — abandoning its pharmaceutical identity for Dogecoin mining, while short sellers who crowded the trade are rushing for the exits. The most…
Li Bang International Corporation Inc. heads into the weekend defined by a single extraordinary data point — short interest plunged 82% in one week, one of the sharpest unwinds in the stock's recent history. The short…
SUNation Energy Inc. heads into next week's earnings with short sellers in full retreat — but the borrow market tells a more complicated story. Short interest has collapsed by 20% over the past week, falling from…
U-BX Technology has become one of the more dramatic setups in US small-cap this week — a stock down 64% in five sessions while short sellers have simultaneously built their largest position on record. Short interest is…
Maris-Tech has spent the past six weeks on an unusual journey — from a heavily-shorted, triple-digit borrow cost situation in early April to a much quieter lending market today. That unwinding is the story worth…
Onfolio Holdings heads into its Q1 2026 earnings call on May 18 with a brutal week behind it — a 23% price decline — and a paradox at its core: short sellers have been abandoning the trade even as the fundamental news…
Allarity Therapeutics enters its Q1 2026 earnings call on May 22 having shed 13% over the past week, and the tension is straightforward: a clinical-stage biotech with no revenue, a binary pipeline, and a print arriving…
Knightscope enters its May 18 investor update carrying one of the most congested short books in its history — 24% of the float is sold short, availability is near rock bottom, and the stock has shed 13% in a…
CERO, the micro-cap biotech trading on OTC markets at $0.027, heads into the back half of May with a dramatic-looking short interest jump that almost entirely dissolves under closer inspection. The headline number is…
P3 Health Partners just delivered one of the most violent single-day moves in the small-cap healthcare space this year. The stock closed May 15 at $11.29 — up 218% on the week and 368% over the past month — after a Q1…
SVRN shed a third of its value in a single week — and this is a stock that was already down 52% over the past month. The week's sharpest story is the speed of short rebuilding after what was a dramatic unwind. Back in…
Incannex Healthcare Inc. heads into its May 22 results with the lending market near maximum tightness — and options traders positioned firmly on the defensive. The borrow story is the week's most striking feature.…
Marpai enters its May 21 earnings call in a dramatically different position than it held just a month ago — short sellers have largely fled, a fresh Q1 report just hit the tape, and the lending market has all but…
GPGI heads into next month's earnings event as one of the most contested setups in its peer group — a sharp post-earnings sell-off, a short interest surge, and a cluster of insiders buying into the slide are all…
Greenidge Generation Holdings posted a 21% gain over the past week to close at $1.47, its best run in months. The stock reported Q1 results after the close on May 15, beating year-ago comparisons — but with short…
Pasithea Therapeutics Corp. heads into mid-May with its most notable story in the lending market: short sellers have been quietly backing away, and the cost to borrow is following them down. Short interest has fallen…
TransCode Therapeutics heads into the back half of May carrying a 26% one-month price loss, a freshly filed shelf registration, and short interest that has just ticked back up after a multi-week retreat. The most…
NRx Pharmaceuticals heads into its May 18 earnings call with short sellers aggressively rebuilding positions and the stock simultaneously pushing higher — a tension that makes this week's setup unusually charged. Short…
